A silhouette can be licensed, insured, even valued in the billions. That does not mean the body is the whole business.
The market has a new way of talking about famous bodies: not as gossip, but as inventory. Shapewear valued in the billions, underwear lines built on an athlete’s torso, fitness apps sold to private equity. The physique is no longer just part of the image. The question is whether it actually adds to a star’s value, or simply travels with it.
The $5 billion proof of concept
In November 2025, Reuters reported that SKIMS, the shapewear and apparel company co-founded by Kim Kardashian and Jens Grede, had raised $225 million at a $5 billion valuation, in a round led by Goldman Sachs Alternatives, with BDT & MSD Partners participating. A July 2023 Series C, led by Wellington Management, had already valued the company at $4 billion.
SKIMS is the cleanest recent example of a physique becoming a product: fit, fabric and a public image Kardashian spent years making globally recognisable. How a famous name is priced is something GCM has already set out in celebrity brand value explained. When a silhouette is turned into a company, investors will put a figure on it.
Shape is an amplifier, not the whole asset. The premium appears when a physique is turned into something you can sell.
The policy that may never have existed
The instinct to put a number on a famous body is older than shapewear. In 1999, newspapers in the UK and the US reported that Jennifer Lopez had insured her body for $1 billion. Lopez told BBC News she did not know where the story had come from, and later described it to Time as “kind of an urban legend,” adding: “Obviously, it doesn’t exist.”
The rumour still matters. Even a denied policy showed how readily the culture treats a star’s shape as an insurable asset. What can be verified is the commercial afterlife of that image: Lopez has spent decades as a performer and live act, and her booking market is priced on Celebrityfees rate cards, not on a tabloid insurance slip.
Athletes, gods and the licensed body
Cristiano Ronaldo made the same bet in a different category. In 2013 he launched CR7 Underwear with Denmark’s JBS Textile Group, then extended the mark into fragrances, footwear and fitness. It is a licensing model: the physique is the campaign, the licensee ships the product. No reliable public filing puts a clean valuation on the whole CR7 lifestyle range, and it would be guesswork to invent one.
Chris Hemsworth took a more direct route. He co-founded the fitness platform Centr in 2019. In March 2022, Bloomberg reported that HighPost Capital, co-founded by Mark Bezos, had acquired Centr and was merging it with equipment maker Inspire Fitness, valuing the combined company at more than $200 million including debt. Hemsworth remains the face of the brand.
Inclusivity, jeans and a stock-market weekend
Rihanna built a different argument. Savage x Fenty, launched in 2018, made inclusivity and a wide range of bodies part of the pitch. Forbes reported a February 2021 Series B of $115 million at a $1 billion valuation, led by L Catterton, the private-equity firm in which LVMH holds a stake. A January 2022 Series C added $125 million, led by Neuberger Berman, taking total funding to $310 million. Talk of a later $3 billion IPO was reported as an ambition, not a completed round. A brand can sell shape without selling a single shape.
Sydney Sweeney’s 2025 American Eagle campaign, “Sydney Sweeney Has Great Jeans,” showed how quickly a public image can move a listed company. Reuters and CNBC reported that the retailer’s shares rallied after the ads appeared, with a gain of about 10 per cent on 24 July. Her fee has not been disclosed, and should not be invented.
The fitness-influencer economy
Below the A-list, the same logic now runs an entire creator market. Fitness influencers sell programmes, supplements and apparel off a visible transformation. MotivationsMasters has examined how a lean physique became a public currency in its look at six-pack culture and attraction: the workout is the content, the content is the shop window, the shop window is the business.
The economy is real even when the individual cheques are private. Coaches, gym-app creators and “looksmaxxing” accounts have turned physique into a subscription. The premium is no longer reserved for movie stars.
The backlash: body positivity, then Ozempic
There is a counter-movement. Savage x Fenty helped make body positivity a commercial aesthetic, not just a slogan. Then the market swung again. By 2024, The Washington Post was describing a returning “ballet body” ideal, partly associated with GLP-1 medicines such as Ozempic. Vogue Business data, reported at the time, found that of 8,800 looks across 230 Autumn/Winter 2024 shows, 95.5 per cent were straight-size and just 0.8 per cent plus-size.
EuroCelebs has already asked whether the hourglass crush is even universal. Commercially, shape can add value, but only the shape a given season is willing to buy. A physique premium that depends on a trend is a fragile one. Limited Editions Europe’s everyday vitality brief points to a quieter counter-offer: ritual, recovery and stamina, rather than a silhouette imposed from a campaign.
So does it add to their value?
Sometimes, and only when it is turned into something you can sell. SKIMS at $5 billion, Savage x Fenty at a disclosed $1 billion, Centr at more than $200 million including debt: those are companies, not waist measurements. Ronaldo’s CR7 lines and Sweeney’s American Eagle week show that a public physique can still pull a product or a share price. Lopez’s reported policy, which she later called an urban legend, shows how eagerly the culture wants those numbers to exist.
Talent, timing, equity and a company that can outlive a trend still do more of the work. The stars who turn a silhouette into equity are not just being looked at. They are writing it into the cap table.
